![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/28/2906122/0/en/NurExone-s-ExoPTEN-Being-Studied-as-Glaucoma-Treatment-for-US-3-4-Billion-Market.html
https://www.fiercepharma.com/pharma/santen-scores-another-fda-eye-drops-nod-time-glaucoma-and-ocular-hypertension
https://www.pharmatimes.com/news/santen_launches_ducressa_for_post-cataract_surgery_1453357
https://investors.aeriepharma.com/news-releases/news-release-details/aerie-concludes-exclusive-license-agreement-santen-rhopressar
https://www.hsa.gov.sg/announcements/product-recall/recall-of-one-batch-of-ikervis-1mg-ml-eye-drop-emulsion